Abstract
Background: Prostate cancer is the second most common reason of mortality due to cancer among men in Poland. The study aimed to determine the waiting time for diagnosis and treatment of prostate cancer. Methods: The study was carried out on patients treated for prostate cancer from May 2014 to February 2015 at five oncological centres in Poland. The median waiting time was measured from the time cancer was suspected to the histopathological diagnosis (SDI), from the cancer suspicion to the start of treatment (STI) and from the diagnosis to the start of treatment (DTI). Results: 123 males treated for prostate cancer were included for analysis. The median time for SDI, STI and DTI was 7.7, 18.7 and 8.7 weeks, respectively. Place of residence was the only factor which influenced STI (p = 0.003). For patients, who started treatment with radiation therapy DTI was longer than for other patients (p < 0.001). Conclusions: Median times of STI, SDI and DTI for prostate cancer patients in Poland are similar to the intervals described in other countries. Patients, who lived further from an oncology centre waited longer for treatment. The impact of waiting time in the case of prostate cancer on improving the prognosis is still unclear.
Highlights
Cancer is a significant global health care problem
One hundred twenty-three consecutive patients were included in the analysis of the waiting time from the cancer suspicion to the start of the treatment
The present study showed that in Poland the time since prostate cancer suspicion till treatment compared to other oncological diseases described in waiting time since prostate cancer suspicion till treatment compared to other oncological diseases our previously report was about eight weeks longer
Summary
Cancer is a significant global health care problem. At present, it is the dominant cause of deaths in the Polish population after cardiovascular diseases [1]. Prostate cancer is the second most common reason of mortality due to cancer among men in Poland, responsible for 8.8% of all cancer deaths [2]. Numerous studies have proved that there is a correlation between the extended time for diagnosis and the start of treatment, with worse outcomes of oncologic therapy of head and neck, breast, lung and cervix cancer [5,6,7,8,9,10,11]. Prostate cancer is the second most common reason of mortality due to cancer among men in Poland. The study aimed to determine the waiting time for diagnosis and treatment of prostate cancer. The median waiting time was measured from the time cancer was suspected to the histopathological diagnosis (SDI), from the cancer suspicion to the start of treatment (STI) and from the diagnosis to the start of treatment (DTI)
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Environmental Research and Public Health
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
